This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 2 CIPO patents. Top assignee: Other. Active years: 2004.
Company Filing History:
1 out of 834,411 Years Active: 2004
Title: Innovations of Steve Arsenault in Glucose Tolerance Prediction
Introduction
Steve Arsenault is an accomplished inventor based in California, known for his significant contributions to the field of glucose tolerance prediction. His innovative work focuses on the genetic aspects of glycerol metabolism and its implications for diabetes management.
Latest Patents
Arsenault holds a patent titled "Glycerol as a predictor of glucose tolerance." This patent describes novel alterations in the glycerol kinase gene. It also outlines methods for predicting or assisting in the prediction of impaired glucose tolerance and type 2 diabetes mellitus.
Career Highlights
Throughout his career, Steve Arsenault has made notable advancements in understanding the genetic factors that influence glucose metabolism. His research has the potential to improve diagnostic methods for diabetes, thereby enhancing patient care and treatment options.
Collaborations
Steve has collaborated with esteemed colleagues, including Mark Daly and John Rioux, to further his research and innovations in the field.
Conclusion
Steve Arsenault's work exemplifies the intersection of genetics and diabetes research, showcasing the importance of innovation in healthcare. His contributions are paving the way for better predictive methods in managing glucose tolerance and diabetes.